Oslo, 3 November 2025, Notification of trade

Following the completion of the merger between BerGenBio and Oncoinvent as
announced on 29 October 2025, merger consideration shares have been delivered to
former shareholders of Oncoinvent as of 29 October 2025 (as registered in
Euronext Securities Oslo on 31 October 2025). Upon receipt of such merger
consideration shares, Geveran Trading Co. Ltd today owns 10,997,008 shares in
Oncoinvent ASA ("Oncoinvent"), representing a total of 7.02% of Oncoinvent's
issued shares and voting rights (based on 156,641,128 shares issued by
Oncoinvent).

 
This disclosure is made pursuant to section 4-2 of the Norwegian Securities
Trading Act and is subject to the disclosure requirement pursuant to section
5-12 of the Norwegian Securities Trading Act.